6 July 2026 - 8 July 2026
USG United Scientific Group,USA
Carrier Scorecards: A Practical Guide for Pharmaceutical Logistics Teams
Pharmaceutical supply chains operate under conditions that leave almost no margin for carrier error. A single temperature excursion can render a shipment unusable. A late delivery to a clinical trial site can delay enrolment. A lost pallet of controlled substances triggers regulatory reporting obligations that consume weeks of compliance work. Against that backdrop, choosing carriers based on rate cards alone is no longer viable, and yet many pharmaceutical logistics teams
Overcoming Supply Chain Bottlenecks with High-Efficiency Single-Use Assembly Solutions
In recent years, the COVID-19 pandemic, geopolitical conflicts and major logistical failures have led to major disruptions in the supply chain. The biopharmaceutical sector, in particular, has felt the impact of these events most sharply, facing exceptional pressure to fast-track vaccine and therapy development within critical timelines.
Where HIPAA Ends and PCI Begins During the Payment Process
The global healthcare industry relies on data, and its pools are endlessly increasing. It’s estimated that as much as 30% of the world’s data volume comes from healthcare alone, accounting for medical records, personally identifiable health information, and cardholder data. With this data usage always growing, there is a critical need to carefully manage and safeguard information stored and processed.
Optimizing Cold Chain Management for Temperature-Sensitive Pharmaceuticals
Prior to the COVID-19 pandemic, the temperature-controlled pharmaceutical supply chain was a somewhat niche industry. However, the urgent need for temperature-controlled storage and transportation of the COVID-19 vaccines accelerated the development of the pharmaceutical cold chain. At the same time, demand for temperature-sensitive pharmaceuticals such as biologics
The Evolving Role of Personal Protective Equipment in Biopharmaceutical Manufacturing
Personal protective equipment (PPE) plays a critical role in ensuring worker safety and maintaining product integrity in biopharmaceutical manufacturing. With the increasing complexity of production, the need for advanced and reliable PPE solutions has never been so great. However, with more than 5.5 million people employed within the industry worldwide, there is a comprehensive network of regulatory standards and evolving safety protocols that aim to minimize contamination
Amgen has announced plans to invest an additional US$300 million in its U.S. manufacturing network to expand domestic production capacity, advance nex...
CSL has announced a $1.5 billion expansion of its manufacturing facility in Kankakee, Illinois, to boost production of plasma-derived therapies and al...
AbbVie has announced a $1.4 billion investment to develop a 185-acre pharmaceutical manufacturing campus in Durham. The advanced site will combine mod...
Johnson & Johnson, a leading and comprehensive healthcare innovation company, today announced an investment of more than $1 billion to build a next-ge...
Shamal Fernando
Managing Director at Slim Pharmaceuticals (Pvt) Ltd, SriLanka, Chartered Marketer , Commercial Leader in Healthcare, Professional Trainer, Pharmaceutical Marketer & Leading Pharmaceutical Importer
Slim Pharmaceuticals ( Pvt) Ltd
Innovations in drug discovery processes
Revolutionizing Medicine: Harnessing the Power of AI in Clinical Trials and Quality Management Systems
Addressing challenges in global supply chain logistics.
Exploring Innovations and Opportunities in the EU CMC Market: A Deep Dive into API and FDF Solutions
Bhupinder Singh Interview - CEO at Messe Muenchen India Pvt. Ltd.
Testimonials
Working with Ochre has been one of the most rewarding experiences of my career. Their attention to detail, innovative approach, and unwavering commitment to excellence set them apart from others in the pharma industry. They are a professional media information platform recognized by the industry. I am confident that anyone who chooses to collaborate with them will be equally impressed. Thanks for making such a positive impact on CPHI & PMEC China.
Informa Markets - Asst Exhibition Sales Manager
.
I have read it with interest. I think it could be of interest to managers and professionals in Asia's Pharma companies as well as global companies that wish to learn more about how to do business--from R&D to marketing-in Asia.
Baoping Wang - Research Director
Novo Nordisk (China) R&D Centre
.webp)
Thank you for contacting us. One of our support staff will get in touch with you shortly.
Happy Surfing!
Regards,
Client Success Team (CRM),
